Best Agrolife Ltd

Best Agrolife Ltd announced that its Board of Directors, in a meeting held on June 27, 2026, noted the lapse of 23,43,750 convertible warrants. These warrants, allotted on December 27, 2024, expired on June 26, 2026, as holders failed to exercise their conversion rights within the 18-month period. Consequently, the company approved the forfeiture of the initial subscription amount totaling ₹37.50 crore, representing 25% of the warrant issue price, as per the terms of issue and SEBI regulations. Details of the warrant holders whose warrants lapsed are provided in Annexure-I.

Best Agrolife Ltd has announced that 23,43,750 warrants, initially allotted on a preferential basis at an issue price of ₹640 per warrant (adjusted to ₹164 post-subdivision), were not exercised for conversion into equity shares by the due date of June 26, 2026. The initial 25% subscription amount received for these warrants is liable for forfeiture as per SEBI regulations. The company's Board of Directors has approved this forfeiture. The entitlement of these warrant holders to receive equity shares stands extinguished.

Best Agrolife Ltd has announced the closure of its trading window for designated persons, effective July 1, 2026, for the quarter ending June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations and the company's internal code of conduct. The trading window will reopen 48 hours after the declaration of the financial results for the said quarter. The date of the board meeting to approve these results will be communicated separately.

Best Agrolife Ltd. released a corporate presentation detailing its activities and strategic direction. In FY26, the company launched three patented formulations (BestmanTM, FetagenTM, Shot DownTM) and secured seven new patents. Despite a challenging Q4 due to the Gulf conflict, which led to a strategic curtailment of sales impacting ₹50-70 crore revenue, the company focused on operational discipline. It implemented two rounds of price increases in April and May 2026 to mitigate rising input costs. Key operational achievements include a significant reduction in inventory levels from ₹958 crore in FY24 to ₹651 crore by March 31, 2026, and a 15% year-on-year reduction in OPEX to ₹280 crore in FY26. The company plans to launch four more patented products in FY27 and will continue its strategy of manufacturing high-value technicals, introducing new products, and controlling expenses.

Best Agrolife Ltd submitted a statement of deviation for the quarter ended March 31, 2026, regarding the utilization of funds raised through a preferential issue of convertible warrants. The company reported deviations in the allocation of funds for capital expenditure and working capital. Originally, ₹70 crores were allocated for capital expenditure, but the board approved ₹50 crores. For working capital, the initial allocation was ₹120 crores, with ₹90 crores approved and ₹37.50 crores utilized. The company issued 31,25,000 convertible warrants and received ₹37.5 crores upfront, with the remaining ₹76.5 crores received later. No funds were utilized during the quarter ended March 31, 2026.

Best Agrolife Ltd's board approved audited financial statements for the year ended March 31, 2026, including standalone and consolidated results. The board recommended a final dividend of ₹0.10 per equity share of ₹1 each for FY26, subject to shareholder approval. M/s SHPH & Associates were appointed as the Internal Auditor for FY 2026-27. The board meeting concluded at 6:15 P.M.

The Board of Directors of Best Agrolife Ltd approved a dividend of ₹0.10 per equity share (10%) for the financial year 2025-26, subject to shareholder approval. The board also approved the audited financial statements and results for the year ended March 31, 2026. Additionally, M/s SHPH & Associates were appointed as the Internal Auditor for FY 2026-27.

Best Agrolife Ltd's board approved audited financial statements (standalone & consolidated) for the year ended March 31, 2026. They recommended a final dividend of ₹0.10 per equity share, subject to shareholder approval. M/s SHPH & Associates were appointed as Internal Auditor for FY 2026-27. The board meeting was held on May 27, 2026. Auditors Walker Chandiok & Co LLP issued an unmodified opinion. The company received notice for reassessment of income for AY 2018-19 to AY 2020-21.

Best Agrolife Ltd has scheduled a Board of Directors meeting on May 27, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend on the company's equity shares for the financial year 2025-26. The trading window for the company's securities will remain closed until May 29, 2026.

Best Agrolife Ltd has released the Monitoring Agency Report by CRISIL Limited for the quarter ended March 31, 2026, pertaining to the utilization of proceeds from a preferential issue of convertible warrants. The report, in compliance with SEBI regulations, confirms that there are no deviations from the stated objectives of the issue. The issuer confirms that the report provides an objective view of the utilization of the issue proceeds.